Jakarta – The Indonesian federal government verified on Monday that no volunteers of Stage III of clinical trials of the Sinovac COVID-19 vaccine in Bandung, West Java, had actually apparently suffered severe symptoms after receiving the vaccine injections.
” The clinical trials have, up until now, run efficiently, and we did not receive any report on those experiencing major results. It indicates that the scientific trials have run efficiently with great outcomes,” Indonesian Foreign Minister Retno Marsudi specified.
Speaking after taking part in a virtual conference with President Joko Widodo, here, Marsudi noted that the Sinovac Biotech delegates had observed the medical trial procedure and the production site of this candidate vaccine at state pharmaceutical holding business PT Bio Farma.
Delegates of this Chinese pharmaceutical company had actually gone to Bandung to witness up close the production website of this prospect vaccine and the medical trial process on Sept 20-24, Marsudi remarked, including that Bio Farma had actually prepared 2 buildings for production sites.
The Chinese delegates visited Building 21 that will serve to produce Sinovac’s candidate vaccine, while Building 43 will function as a production site for other prospect vaccines, consisting of those obtained from an international mechanism, she remarked.
Bio Farma had increased its production capacity, from 100 million dosages to 250 million dosages of the COVID-19 vaccine, Marsudi revealed, adding that the Indonesian Food and Drug Tracking Company (BPOM) delegates will also go to Sinovac’s facilities in China as part of the government’s preventive procedures in preparing the vaccines to be used in Indonesia.
The phase III of scientific trials of the Sinovac COVID-19 vaccine has been carried out since August this year, and if the BPOM states that its results are safe, the vaccine can be enormously produced and dispersed to the public.
ANTARA kept in mind that on Aug 30, 2020, the Padjadjaran University’s Research Team for the Medical Trials of Sinovac COVID-19 Vaccine revealed that 248 volunteers, including West Java Guv Ridwan Kamil, had been administered the vaccine.
As numerous as 21 of the 248 volunteers had actually also received the second vaccine injections without exhibiting serious signs, the Unpad’s research team supervisor, Eddy Fadliyana, noted in a declaration.
None of the participating volunteers suffered serious symptoms after getting the very first and second vaccine injections, Fadliyana stated, adding that research study on the clinical trials can be concluded effectively to make it possible for the vaccine to be produced.
Among the volunteers that have received the vaccine injections are West Java Governor Ridwan Kamil and numerous officials of the provincial government.
The volunteers participating in phase III of the clinical trials got the vaccine injections at a number of university hospital, including Unpad’s Health Center and Professors of Medication as well as the Garuda, Ciumbuleuit, Dago, and Sukapakir Public Health Centers.
Unique coronavirus infections initially emerged in the Chinese city of Wuhan at the end of 2019.
Ever since, COVID-19 has spread to over 215 nations and territories, consisting of 34 provinces of Indonesia, with a huge spurt in death toll.
To tackle this COVID-19 pandemic, Indonesia is leaving no stone unturned to establish a vaccine to fight the virus.
Currently, in addition to the Sinovac COVID-19 vaccine, Indonesian researchers are working on a vaccine called after the nation’s national flag, Merah Putih (Red and White).
Associated news: Jokowi urges government authorities to prepare COVID-19 vaccination plan
Related news: Federal government constantly ventures to expedite vaccine availability
.
EDITED BY INE
